肿瘤预防与治疗2024，Vol.37Issue(1)：1-19,19.DOI:10.3969/j.issn.1674-0904.2024.01.001
癌痛患者自控静脉镇痛技术临床实践规范的四川专家共识
Sichuan Expert Consensus on Patient-Controlled Intravenous Analgesia Technology for Cancer Pain Patients
摘要
Abstract
Patient-controlled intravenous analgesia(PCIA)is a commonly used individualized treatment for patients with cancer pain,which is suitable for patients with difficulty in oral medication,poor pain control by taking large doses of oral drugs or the pain in terminal stage cancer,and it is also the main treatment of intractable cancer pain and breakthrough cancer pain.Strong opioids are preferred in PCIA,and adjuvant therapy drugs can be selected according to the actual situation of patients.PCIA is characterized by rapid onset,stable blood concentration,no analgesic blind area,and on-demand administration.In order to better standardize the application of PCIA technology in cancer pain management in Sichuan Province,the Cancer Pain Expert Committee of Sichuan Anti-cancer Association has formulated this expert consensus on the basis of widely drawing lessons from domestic and foreign guidelines and norms,with the experience of multidisciplinary treatment and full-course management of cancer pain in Sich-uan Province,with a view to providing guidance and suggestions for clinical practice.关键词
癌痛/患者自控静脉镇痛/阿片类药物/癌性爆发痛/专家共识Key words
Cancer pain/Patient-controlled intravenous analgesia/Opioids/Breakthrough cancer pain/Expert consensus分类
医药卫生引用本文复制引用
四川省抗癌协会肿瘤疼痛学专家委员会,文彦,魏阳..癌痛患者自控静脉镇痛技术临床实践规范的四川专家共识[J].肿瘤预防与治疗,2024,37(1):1-19,19.基金项目
This study was supported by grants from Health Commission of Sichuan Province(No.20SYJS06). 四川省卫生健康委适宜技术推广项目(编号:20SYJS06) （No.20SYJS06）
